Skip to content

A study to evaluate if an online parent training programme can help to improve language development in young deaf children with cochlear implants

IMPACT (IMplemented by Parents And Carers Therapy) trial: A multicentre randomised controlled trial to evaluate the efficacy of a parent-implemented therapy on language development in deaf children with cochlear implants

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN54645261
Enrollment
158
Registered
2025-04-29
Start date
2025-07-01
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parent-implemented therapy on language development in deaf children with cochlear implants Ear, Nose and Throat

Interventions

This trial aims to find out whether a parent-led programme called "It Takes Two to Talk" (ITTT) can help young children with cochlear implants (CIs) develop better language skills than they would with

Sponsors

University of Nottingham
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Children: 1. Aged less than 5 years old at time of CI surgery 2. Meets UK NICE criteria for bilateral cochlear implantation 3. Bilateral cochlear implants with full electrode insertion in both ears 4. History, examination and pre-operative imaging suggests a structurally normal and fully patent cochlea with normal cochlear nerves bilaterally Parents: 1. Capable of understanding and speaking English 2. Ability to provide informed consent NB: Parents will be recruited and consented once the child’s CI implantation surgery has been confirmed. Prior to randomisation, eligibility criteria in relation to CI surgery will be assessed and children not meeting the criteria will not be randomised into the trial.

Exclusion criteria

Exclusion criteria: Children: 1. Incomplete electrode insertion in one or both ears 2. Developmental disorders known to impact on CI outcome including but not limited to brain injury, brain tumour, Down syndrome, and fragile X syndrome 3. English not the dominant spoken language at home (including British Sign Language (BSL)) 4. Structural brain malformation, severely malformed cochlea, Auditory Neuropathy Spectrum Disorder, cochlear nerve deficiency and/or post-meningitis deafness 5. Any known factor that may restrict full insertion of the electrode array 6. Participation in any other CI intervention clinical trial Parents 1. English not the dominant spoken language at home (including BSL)

Design outcomes

Primary

MeasureTime frame
Receptive language development is assessed using the Auditory Comprehension subscale of the Preschool Language Scale – Fifth Edition PLS-5 UK at baseline and 12-months post-randomisation

Secondary

MeasureTime frame
1. Receptive language development - measured by the PLS-5 Auditory comprehension subscale at 6 months post randomisation 2. Expressive language development - measured by the PLS-5 Expressive communication subscale at baseline, 6-months and 12-months post randomisation 3. Childhood developmental milestones - measured by the Schedule of Growing Skills questionnaire (SGS) at baseline and 12-months post-randomisation 4. Child Behaviour measured by the Strengths and Difficulties Questionnaire (SDQ) at baseline and 12-months post-randomisation 5. Social emotional functioning measured by the Ages and Stages Questionnaire: Social Emotional – 2 (ASQ:SE-2) at baseline and 12-months post-randomisation 6. Pragmatic language development measured using the Language Use Inventory (LUI) at baseline and 12-months post-randomisation

Countries

England, United Kingdom

Contacts

Public ContactLouise Nicholson-Scott
louise.nicholson-scott@nottingham.ac.uk+44 115 823 1587

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026